Which treatment works best for lowering apnea-hypopnea index in obstructive sleep apnea patients?
The apnea-hypopnea index (AHI) measures how often your breathing pauses or becomes shallow per hour of sleep. Lowering AHI is the main goal of obstructive sleep apnea (OSA) treatment. Based on a network meta-analysis of 34 trials, continuous positive airway pressure (CPAP) is the most effective treatment for reducing AHI. GLP-1 receptor agonists (like liraglutide and tirzepatide) also help, especially by improving weight and metabolic factors, but CPAP has the strongest direct effect on AHI.
What the research says
A 2025 network meta-analysis compared CPAP, GLP-1 receptor agonists (such as liraglutide and tirzepatide), their combination, and no active treatment in adults with OSA 3. CPAP produced the largest reduction in AHI, lowering it by an average of 22.17 events per hour compared to no treatment 3. CPAP also improved daytime sleepiness, measured by the Epworth Sleepiness Scale, by about 2.75 points 3. In contrast, liraglutide did not significantly reduce AHI but did lower body mass index (BMI) by 1.60 kg/m² and improved blood sugar control 3. Combining liraglutide with CPAP led to the greatest BMI reduction (2.00 kg/m²) 3. Tirzepatide, another GLP-1 medication, has been studied for weight loss and is cost-effective compared to semaglutide in people with obesity, including those at risk for OSA 5. However, the meta-analysis did not find that any GLP-1 drug alone matched CPAP's effect on AHI 3. CPAP compliance is also linked to better survival in heart failure patients with OSA who have a left ventricular assist device 4. Overall, CPAP remains the gold standard for directly lowering AHI, while GLP-1 medications are valuable for addressing obesity and metabolic issues that often accompany OSA.
What to ask your doctor
- What is my current AHI, and what would be a realistic target for treatment?
- Would CPAP therapy be a good option for me, and what can I do to improve comfort and adherence?
- Could a GLP-1 medication (like liraglutide or tirzepatide) help with weight loss and metabolic health alongside CPAP?
- Are there any risks or side effects I should know about with CPAP or GLP-1 drugs?
- How often should I have follow-up sleep studies to check if my AHI is improving?
This question is drawn from common patient questions about Pulmonology & Critical Care and answered using cited medical research. We do not provide individualized advice.